Published in Nat Rev Clin Oncol on August 18, 2009
Sirolimus in Treating Patients With Advanced Pancreatic Cancer | NCT00499486
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer | NCT00409292
Concern Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells. PLoS One (2013) 1.49
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model. Mol Cancer Ther (2010) 1.34
Genetic and epigenetic alterations in pancreatic carcinogenesis. Curr Genomics (2011) 1.33
Advances in biomarker research for pancreatic cancer. Curr Pharm Des (2012) 1.05
Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One (2013) 1.03
Pituitary stem cell update and potential implications for treating hypopituitarism. Endocr Rev (2011) 0.99
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine. BMC Cancer (2012) 0.91
Carcinogenesis of pancreatic adenocarcinoma: precursor lesions. Int J Mol Sci (2013) 0.91
Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg (2011) 0.90
Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer (2011) 0.85
Catechol-O-methyltransferase, a new target for pancreatic cancer therapy. Cancer Sci (2015) 0.82
Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Stem Cell Res (2012) 0.82
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis. PLoS One (2016) 0.80
A tissue-engineered subcutaneous pancreatic cancer model for antitumor drug evaluation. Int J Nanomedicine (2013) 0.80
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 16.56
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development (2002) 12.21
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature (2006) 11.86
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature (2005) 11.49
Tumor growth need not be driven by rare cancer stem cells. Science (2007) 10.34
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33
Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell (2008) 8.57
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature (2003) 8.14
The multiple roles of PTEN in tumor suppression. Cell (2000) 6.71
Stem cells and cancer: two faces of eve. Cell (2006) 6.13
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell (2003) 5.36
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res (2007) 5.12
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res (2002) 5.00
Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst (1970) 4.88
Generation and regeneration of cells of the liver and pancreas. Science (2008) 4.21
A multipotent progenitor domain guides pancreatic organogenesis. Dev Cell (2007) 4.13
Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol (2007) 4.12
PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet (2007) 4.09
CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol (2004) 4.08
Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells (2005) 3.66
Normal stem cells and cancer stem cells: the niche matters. Cancer Res (2006) 3.60
The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene (2005) 3.42
Notch signaling in development and cancer. Endocr Rev (2007) 3.22
A side order of stem cells: the SP phenotype. Stem Cells (2006) 2.73
Cancer stem cells--old concepts, new insights. Cell Death Differ (2008) 2.56
Side population cells in human cancers. Cancer Lett (2008) 2.53
Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med (2007) 2.29
Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer (2005) 2.20
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity. Cancer Res (2008) 2.15
Cancer stem cells: a step toward the cure. J Clin Oncol (2008) 2.08
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer (2008) 1.93
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer (2008) 1.82
Successful therapy must eradicate cancer stem cells. Stem Cells (2006) 1.78
Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas (2007) 1.68
Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int (2007) 1.67
Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res (2004) 1.60
"Destemming" cancer stem cells. J Natl Cancer Inst (2007) 1.51
Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol (2008) 1.41
Pancreatic stem cells. J Pathol (2002) 1.36
The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol (2003) 1.31
Cancer stem cells in human gastrointestinal cancers. Hum Cell (2006) 1.30
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol (2006) 1.23
Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J Gastroenterol (2008) 1.18
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery (2003) 1.14
Pituitary progenitor cells tracked down by side population dissection. Stem Cells (2009) 1.10
Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet (2008) 1.09
The cancer stem cell theory: is it correct? Mol Cells (2008) 1.06
Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res (2008) 1.04
Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood (2002) 1.02
Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol (2007) 0.94
The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology (2008) 0.92
Expression of CD44 variants and its association with survival in pancreatic cancer. Jpn J Cancer Res (1998) 0.92
Kinetic analyses as a critical parameter in defining the side population (SP) phenotype. Exp Cell Res (2007) 0.88
Biomedical applications of poisonous plant research. J Agric Food Chem (2004) 0.87
Pancreatic lineage analysis using a retroviral vector in embryonic mice demonstrates a common progenitor for endocrine and exocrine cells. Int J Dev Biol (2002) 0.86
Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas (2007) 0.85
Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma. Cancer Sci (2003) 0.83
Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells. Hepatogastroenterology (2008) 0.81
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology (2012) 2.49
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut (2013) 2.10
Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up. Surg Endosc (2013) 2.01
The dark side of EGFP: defective polyubiquitination. PLoS One (2006) 1.49
The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology (2005) 1.38
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization. J Clin Invest (2014) 1.20
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol (2009) 1.16
History and perspectives of pituitary folliculo-stellate cell research. Eur J Endocrinol (2005) 1.13
Pituitary progenitor cells tracked down by side population dissection. Stem Cells (2009) 1.10
Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PLoS One (2013) 1.03
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery. BMC Cancer (2012) 1.02
Molecular markers associated with outcome and metastasis in human pancreatic cancer. J Exp Clin Cancer Res (2012) 1.02
Nestin-immunoreactive cells in rat pituitary are neither hormonal nor typical folliculo-stellate cells. Endocrinology (2005) 1.02
Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood--a systematic review. J Surg Res (2008) 0.99
Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS One (2011) 0.98
The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population. Mol Endocrinol (2006) 0.97
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine. BMC Cancer (2012) 0.91
Partial laparoscopic splenectomy for splenic abscess because of Salmonella infection: a case report. J Pediatr Surg (2008) 0.90
The adult pituitary shows stem/progenitor cell activation in response to injury and is capable of regeneration. Endocrinology (2012) 0.90
Systemic treatment of pancreatic cancer. Eur J Gastroenterol Hepatol (2004) 0.89
Stem cells in the pituitary gland: A burgeoning field. Gen Comp Endocrinol (2009) 0.88
Gene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusion. Pigment Cell Melanoma Res (2012) 0.88
Activated phenotype of the pituitary stem/progenitor cell compartment during the early-postnatal maturation phase of the gland. Stem Cells Dev (2011) 0.86
Outcome of laparoscopic major liver resection for colorectal metastases. Surg Endosc (2012) 0.86
Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer (2011) 0.85
The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS One (2013) 0.85
Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice. J Biol Chem (2010) 0.83
Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies. J Surg Oncol (2010) 0.82
Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic ablation. Stem Cells Dev (2012) 0.81
Fixation and paraffin-embedding of mouse tissues for GFP visualization. Cold Spring Harb Protoc (2009) 0.81
Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. Ann Surg Oncol (2009) 0.78
The dog liver contains a "side population" of cells with hepatic progenitor-like characteristics. Stem Cells Dev (2009) 0.78
Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma. Hepatol Res (2012) 0.78
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma. Radiat Oncol (2008) 0.77
Identification and characterisation of side population cells in the canine pituitary gland. Vet J (2011) 0.76
Pituitary cell differentiation from stem cells and other cells: toward restorative therapy for hypopituitarism? Regen Med (2014) 0.76
Minimally invasive liver surgery for metastases from colorectal cancer: oncologic outcome and prognostic factors. Surg Endosc (2013) 0.75
On hazard ratios and magnitude of impact on prognosis. Ann Surg (2009) 0.75
Pancreaticogastrostomy after pancreaticoduodenectomy? Lancet Oncol (2013) 0.75
Beta1-adrenoceptor expression in rat anterior pituitary gonadotrophs and in mouse alphaT3-1 and LbetaT2 gonadotrophic cell lines. Endocrinology (2008) 0.75